245 related articles for article (PubMed ID: 18990124)
21. Gene Therapy for Treatment of Brain Tumors (HSV-tKIn Vivo Gene Transfer) : A Case Study.
Weber F; Floeth F; Bojar H
Methods Mol Med; 2000; 35():499-509. PubMed ID: 21390826
[TBL] [Abstract][Full Text] [Related]
22. Molecular mechanisms in gliomagenesis.
Hulleman E; Helin K
Adv Cancer Res; 2005; 94():1-27. PubMed ID: 16095998
[TBL] [Abstract][Full Text] [Related]
23. The EGFRvIII variant in glioblastoma multiforme.
Gan HK; Kaye AH; Luwor RB
J Clin Neurosci; 2009 Jun; 16(6):748-54. PubMed ID: 19324552
[TBL] [Abstract][Full Text] [Related]
24. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
[TBL] [Abstract][Full Text] [Related]
25. [Progress in the study of brain tumor stem cells as treatment targets].
Hide T; Kuratsu J
Brain Nerve; 2009 Jul; 61(7):781-9. PubMed ID: 19618855
[TBL] [Abstract][Full Text] [Related]
26. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
[TBL] [Abstract][Full Text] [Related]
27. Treatment options for recurrent glioblastoma: pitfalls and future trends.
Franceschi E; Tosoni A; Bartolini S; Mazzocchi V; Fioravanti A; Brandes AA
Expert Rev Anticancer Ther; 2009 May; 9(5):613-9. PubMed ID: 19445578
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic mechanisms in glioblastoma multiforme.
Nagarajan RP; Costello JF
Semin Cancer Biol; 2009 Jun; 19(3):188-97. PubMed ID: 19429483
[TBL] [Abstract][Full Text] [Related]
29. Recurrent glioblastoma: a fresh look at current therapies and emerging novel approaches.
Gilbert MR
Semin Oncol; 2011 Dec; 38 Suppl 4():S21-33. PubMed ID: 22078645
[TBL] [Abstract][Full Text] [Related]
30. Targeting multiple kinases in glioblastoma multiforme.
Sathornsumetee S; Reardon DA
Expert Opin Investig Drugs; 2009 Mar; 18(3):277-92. PubMed ID: 19243279
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic strategies for inhibiting invasion in glioblastoma.
Drappatz J; Norden AD; Wen PY
Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303
[TBL] [Abstract][Full Text] [Related]
32. Translating biology into clinic: the case of glioblastoma.
Lino M; Merlo A
Curr Opin Cell Biol; 2009 Apr; 21(2):311-6. PubMed ID: 19217766
[TBL] [Abstract][Full Text] [Related]
33. Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme.
McGirt MJ; Mukherjee D; Chaichana KL; Than KD; Weingart JD; Quinones-Hinojosa A
Neurosurgery; 2009 Sep; 65(3):463-9; discussion 469-70. PubMed ID: 19687690
[TBL] [Abstract][Full Text] [Related]
34. Glioblastoma-derived mechanisms of systemic immunosuppression.
Waziri A
Neurosurg Clin N Am; 2010 Jan; 21(1):31-42. PubMed ID: 19944964
[TBL] [Abstract][Full Text] [Related]
35. A fatal outcome in a patient with glioblastoma multiforme after receiving high-dose methotrexate.
Price S; Harless W; Rikhye S; Altaha R
J Oncol Pharm Pract; 2008 Mar; 14(1):57-60. PubMed ID: 18337442
[TBL] [Abstract][Full Text] [Related]
36. Evo-Devo and the evolution of cancer: a hypothesis for metamorphic therapies for the cancers of prolactin-influenced tumourigenesis: with special reference to glioblastoma multiforme (GBM).
Pearson RD
Med Hypotheses; 2009 Jun; 72(6):629-30. PubMed ID: 19250755
[TBL] [Abstract][Full Text] [Related]
37. Treatment options for malignant gliomas, emphasizing towards new molecularly targeted therapies.
Argyriou AA; Antonacopoulou A; Iconomou G; Kalofonos HP
Crit Rev Oncol Hematol; 2009 Mar; 69(3):199-210. PubMed ID: 18602834
[TBL] [Abstract][Full Text] [Related]
38. Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical trials.
Quant EC; Wen PY
Neuroimaging Clin N Am; 2010 Aug; 20(3):425-48. PubMed ID: 20708556
[TBL] [Abstract][Full Text] [Related]
39. 'Recurrent' glioblastoma multiforme, when should we reoperate?
Barbagallo GM; Jenkinson MD; Brodbelt AR
Br J Neurosurg; 2008 Jun; 22(3):452-5. PubMed ID: 18568742
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic Potential of Curcumin in the Treatment of Glioblastoma Multiforme.
Shahcheraghi SH; Zangui M; Lotfi M; Ghayour-Mobarhan M; Ghorbani A; Jaliani HZ; Sadeghnia HR; Sahebkar A
Curr Pharm Des; 2019; 25(3):333-342. PubMed ID: 30864499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
